More than 1,750 standalone Medicare Part D prescription drug plans will offer the lower insulin copays through the Part D Senior Savings Model for the 2021 plan year.
The $35 per month cap applies to both pen and vial dosage forms for rapid-acting, short-acting, intermediate-acting and long-acting insulin.
More than 3.3 million Medicare beneficiaries use one or more common forms of insulin, and they could see annual savings of about $446 for insulin, CMS said in a news release.
More articles on pharmacy:
AstraZeneca gets $1B from US to produce COVID-19 vaccine
7 things to know about startup drugmaker Phlow
Consumers still feel comfortable picking up prescriptions at pharmacies, survey says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
